Craig Halberstadt
Plus aucun poste en cours
Profil
Craig Halberstadt worked as a Director of Product Development at Advanced Tissue Sciences, Inc., Senior Director of Process Development at Tengion, Inc., Director of Surgical Research at Carolinas Medical Center, Director of Tissue Engineering at Desmos, Inc., and Vice President of Process Development and Technical Operations at Organovo, Inc. He also worked as the Senior Vice President of Research and Product Development at Asterias Biotherapeutics, Inc. Halberstadt earned a doctorate degree from the University of Michigan.
Anciens postes connus de Craig Halberstadt
| Sociétés | Poste | Fin |
|---|---|---|
| ASTERIAS BIOTHERAPEUTICS INC | Directeur Technique/Scientifique/R&D | 01/03/2019 |
| Advanced Tissue Sciences, Inc. | Corporate Officer/Principal | - |
Desmos, Inc.
 Desmos, Inc. Packaged SoftwareTechnology Services Desmos, Inc. develops a platform for building and sharing educational content. It offers graphing calculator, a browser based math software which is used by students, teachers, researchers, and general math enthusiasts. The firm provides other software that runs in any browser, offering virtual whiteboard capability for remote, real time collaboration, teaching and tutoring and software that permits tutoring companies to manage their resources and client interactions. The company was founded in 2007 by Eli Luberoff and is headquartered in San Francisco, CA. | Corporate Officer/Principal | - |
| Carolinas Medical Center (Charlotte) | Corporate Officer/Principal | - |
| TENGION, INC. | Corporate Officer/Principal | - |
Formation de Craig Halberstadt
| University of Michigan | Doctorate Degree |
Expériences
Fonctions occupées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| TENGION, INC. | Health Technology |
| Entreprise privées | 5 |
|---|---|
Asterias Biotherapeutics, Inc.
 Asterias Biotherapeutics, Inc. BiotechnologyHealth Technology Asterias Biotherapeutics, Inc. is a clinical-stage biotechnology company, which focuses on developing and commercializing novel therapies in the emerging fields of cell therapy and regenerative medicine. Its product candidates include AST-OPC1, trial for spinal cord injuries; AST-VAC1, a patient specific cancer immunotherapy focused on acute myeloid leukemia; and AST-VAC2, a non-patient-specific cancer immunotherapy for non-small cell lung cancer. The company was founded on September 24, 2012 and is headquartered in Fremont, CA. | Health Technology |
Organovo, Inc.
 Organovo, Inc. Medical/Nursing ServicesHealth Services Organovo, Inc. develops and supplies pharmaceutical products. It focuses on delivering human tissue printing technology and creating tissue on demand for research and surgical applications. The firm helps physicians and researchers fulfill the promise of regenerative medicine by overcoming problems in cardiovascular medicine, medical research and transplant medicine. The company was founded by Eric Michael David, Andras Forgacs, Gabor Forgacs and Keith Murphy in 2007 and is headquartered in San Diego, CA. | Health Services |
| Carolinas Medical Center (Charlotte) | |
Desmos, Inc.
Desmos, Inc. Packaged SoftwareTechnology Services Desmos, Inc. develops a platform for building and sharing educational content. It offers graphing calculator, a browser based math software which is used by students, teachers, researchers, and general math enthusiasts. The firm provides other software that runs in any browser, offering virtual whiteboard capability for remote, real time collaboration, teaching and tutoring and software that permits tutoring companies to manage their resources and client interactions. The company was founded in 2007 by Eli Luberoff and is headquartered in San Francisco, CA. | Technology Services |
| Advanced Tissue Sciences, Inc. | Commercial Services |
